Where does Scalpal LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Scalpal LLC ranks #15,592 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Scalpal LLC hold?

Scalpal LLC holds 19 US utility patents granted between 2015 and 2024, spanning 9 technology areas.

What is Scalpal LLC's Innovation Score?

Scalpal LLC has an Innovation Score of 35.7 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Scalpal LLC's patent grant rate increasing or decreasing?

Scalpal LLC's recent grant velocity is +38% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Scalpal LLC's patents?

Scalpal LLC's patents average 15.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Scalpal LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Scalpal LLC

Q: What technology areas does Scalpal LLC focus on?

Scalpal LLC's top technology area is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle) with 6 patents, ranking #178 of 903 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 19 granted patents across 9 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Scalpal ranks #15,592 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 9 technology areas.

#15,592
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.7/100): 15.0
avg claims per patent: +38%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15592 · US Corporation #15,592 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 19 grants
MID-PACK #15,592/49,997
PHOTO-FINISH Sakura Seiki
CPC-NARROW A61J · 9 areas
INNOV-THIN 35.7/100
CLAIMS-RICH 15.0 claims/avg
TYPE-USCORP US Corporation
VEL-UP +38% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sakura Seiki Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Scalpal’s 35.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.3 pts (29%) Velocity 5.7 pts (16%) Breadth 10.6 pts (30%) Claim depth 9.0 pts (25%)

Qualcomm Incorporated · highest

85
Scalpal · this assignee

36
3D Lighting… · lowest

7

What this shows Scalpal's Innovation Score is 35.7/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Scalpal?

Each dot is one of Scalpal’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Scalpal’s own 15.0 claims/patent is ABOVE the 7.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Scalpal vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Scalpal's grants concentrate

Scalpal LLC is a focused PatentsView assignee: 9 CPC subclasses with 31.6% of grants classified under A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2017. By volume, Scalpal sits between S.I.SV.EL. Societa' Italiana Per Lo Sviluppo Dell' Elettronica S.P.A. and Secure Thingz Ltd..

Scalpal's three-year grant acceleration

Scalpal LLC shows 6 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

S I SV EL Societa…

19
S R Smith

19
Sakura Seiki

19
Santa & Cole Neos…

19
Schattdecor

19
Schweizer

19
Seabery North Ame…

19
Secure Thingz

19
Scalpal ◀

19

What this shows Scalpal holds 19 patents at rank #15,586, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Scalpal

By rank, the assignees closest to #15,586 in granted patent volume.

Leaders in A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…)

Other assignees with the most granted patents in Scalpal's primary technology class.

Scalpal's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Scalpal LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	15.8%
2016	2	10.5%
2017	1	5.3%
2019	2	10.5%
2020	2	10.5%
2021	3	15.8%
2022	3	15.8%
2024	3	15.8%

Which technologies does Scalpal LLC patent most?

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 6

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

F16B - Devices FOR Fastening OR Securing Constructional Elements OR Machine Parts Together, e.g. Nails, Bolts, Circlips, Clamps, Clips OR WEDGES; Joints OR Jointing 5

B25B - Tools OR Bench Devices NOT Otherwise Provided FOR, FOR Fastening, Connecting, Disengaging OR Holding 5

A61B - DIAGNOSIS; SURGERY; Identification 4

A47G - Household OR Table Equipment 1

F16M - Frames, Casings OR Beds OF Engines, Machines OR Apparatus, NOT Specific TO Engines, Machines OR Apparatus Provided FOR ELSEWHERE; STANDS; Supports 1

B25G - Handles FOR Hand Implements 1

A61C - DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Scalpal LLC's patent record in context - here's where to go next.

Scalpal LLC's lead technology class is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ), 31.6% of its portfolio - see every assignee active in that class. Explore A61J
Ranked #15,592 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Scalpal LLC against S.I.SV.EL. Societa' Italiana Per Lo Sviluppo Dell' Elettronica S.P.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.